FDA Investigating Mysterious Deaths With Eli Lilly’s Anti-Psychotic Drug

June 26, 2013
The FDA is investigating the deaths of two patients who died three to four days after receiving an injection of Eli Lilly’s long-acting, anti-psychotic drug Zyprexa Relprevv. The agency and Lilly have both emphasized that it’s not clear if the drug was the cause.
Washington Drug Letter